"Molecular fingerprinting" offers new opportunities in cancer diagnosis

08/5/2010 | Science Blog

U.S. researchers have developed a diagnostic chip that uses a combination of microfluidics and microscopy-based imaging to create single-cell "molecular fingerprints" for brain tumor samples. The microfluidic image cytometry platform allows researchers to make in vitro molecular measurements to identify patterns that could aid in detailing patient prognosis and creating personalized cancer therapies.

View Full Article in:

Science Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC